SouthState’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
Other funds holding ROIV
SouthState's ROIV Position: Q3 2026 in Review
SouthState held its Roivant Sciences (ROIV) position steady in Q3 2026 at 45 shares worth $1.65K. The position accounts for ﹤0.01% of the portfolio, ranked #1018.
SouthState first reported a position in ROIV in Q1 2025 and has held it in 7 quarters since. The position peaked at $2K in Q3 2025. 395 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.
- SouthState held 45 shares of Roivant Sciences worth $1.65K as of Q3 2026.
- SouthState left its Roivant Sciences share count unchanged in Q3 2026.
- Roivant Sciences made up ﹤0.01% of SouthState's portfolio in Q3 2026, its #1018 holding.
- SouthState first reported a position in Roivant Sciences in Q1 2025 and has held it in 7 quarters since.
- SouthState's Roivant Sciences position peaked at $2K in Q3 2025.
- 395 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.
Based on SouthState's 13F filing for Q3 2026, filed 9 Nov 2026.